Jeff Legos

Jeff Legos is the Executive Vice President and Global Head of Oncology & Hematology Development at Novartis, a position he has held since June 2021.1 He has an extensive background in the pharmaceutical industry, particularly in oncology research and development.

Career Progression

• Senior Vice President, Global Head of Oncology Development at Novartis (May 2019 - May 2021)1
• SVP, Franchise Global Program Head at Novartis (March 2017 - April 2019)1
• SVP, Global Program Head at Novartis (May 2015 - March 2017)1
• Vice President, Medicines Development Leader at GSK Oncology R&D (June 2010 - April 2015)1
• Head, Business Planning Strategy, Portfolio Management, & Executive Operations at GSK Oncology R&D (June 2008 - October 2010)1
• Senior Director, Clinical Program & Portfolio Leader - Oncology Discovery and Development at GSK Oncology R&D (June 2006 - June 2008)1

Education

• Villanova University School of Business (2001 - 2004)1
• Temple University School of Medicine (1996 - 2000)1

Recent Activities

Legos has been actively involved in Novartis' oncology efforts, sharing updates on LinkedIn about the company's initiatives and achievements in cancer treatment.234 He has highlighted Novartis' commitment to reimagining medicine for patients living with cancer and has presented at industry events such as EHA2024.5